2 completed, 1 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Hyperkinesis: new trials by email Literature Review of Hyperkinesis trials Research Report on Hyperkinesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. Antisense oligonucleotide treatment (ASO) - GNAO1, Epilepsy | Phase 1 / Phase 2 | Recruiting | Pirogov Russian National Research Medical University | 5 | 2025-09-09 | 2026-01-23 |
| Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial Tipepidine Hibenzate, Placebo - Attention Deficit Disorder With Hyperactivity Disease, Hyperkinesis | Phase 1 / Phase 2 | Completed | Chiba University | 21 | 2015-06-11 | 2019-03-19 |
| Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients Lobeline sulfate, Methylphenidate HCl, Placebo - Attention Deficit Disorder With Hyperactivity | Phase 2 | Completed | Yaupon Therapeutics | 13 | 2008-07-01 | 2013-06-20 |
Attention Deficit and Disruptive Behavior Disorders (2) · Attention Deficit Disorder with Hyperactivity (1) · Dyskinesias (1) · Epilepsy (1) · Neurodevelopmental Disorders (1) · Neurologic Manifestations (1)
Nervous System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Central Nervous System Diseases (2) · Dyskinesias (2) · Mental Disorders (2) · Neurologic Manifestations (2) · Brain Diseases (1) · Movement Disorders (1) · Neurodevelopmental Disorders (1)
Lobeline (1) · Methylphenidate (1) · tipepidine (1)
Chiba University (1) · Pirogov Russian National Research Medical University (1) · Yaupon Therapeutics (1)
Japan (1) · Russia (1) · United States (1)
Catherine A. Martin, MD (1) · Elena D Belousova, Prof (1)
R43MH081553 (1)